Abdullah Ali
Urology · Yonkers, NYNPI 1255845053
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,565 of the $11,279 with a category attached, or 67.1%. It is spread thinly across 37 manufacturers, the largest accounting for just 18.5%.
Across 315 payments — averaging $35.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Johnson & Johnson$1K
- Procept Biorobotics Corporation$1K
- Astellas Pharma US Inc$876
- Endo Pharmaceuticals Inc.$618
- Myovant Sciences Inc.$500
- plus $4K from 31 others
What the payments were for
- Travel & lodging$2,77325%
- Food & beverage$7,56567%
- Education$9418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 20 | $2,085 |
| Johnson & Johnson | 67 | $1,410 |
| Procept Biorobotics Corporation | 8 | $1,350 |
| Astellas Pharma US Inc | 20 | $876 |
| Endo Pharmaceuticals Inc. | 27 | $618 |
| Myovant Sciences Inc. | 20 | $500 |
| Sumitomo Pharma America, Inc. | 17 | $447 |
| Myriad Genetic Laboratories, Inc. | 21 | $421 |
| Coloplast | 8 | $376 |
| Pfizer | 16 | $354 |
| AbbVie(2 entities) | 12 | $351 |
| Medtronic | 2 | $321 |
| Aytu Biopharma, Inc. | 5 | $276 |
| Urovant Sciences Inc | 2 | $250 |
| Teleflex LLC | 5 | $178 |
| Tolmar, Inc. | 8 | $177 |
| Clarus Therapeutics Inc. | 7 | $148 |
| Progenics Pharmaceuticals, Inc. | 5 | $137 |
| Blue Earth Diagnostics | 6 | $129 |
| Dentsply IH AB | 5 | $109 |
| Antares Pharma, Inc. | 5 | $106 |
| Acerus Pharmaceuticals Corporation | 5 | $99 |
| Therapeuticsmd, Inc. | 2 | $91 |
| Alnylam Pharmaceuticals Inc. | 3 | $69 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| Boston Scientific | 2 | $46 |
| Novo Nordisk | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Urogen Pharma, Inc. | 2 | $33 |
| Photocure Inc | 2 | $31 |
| Neotract Inc. | 1 | $29 |
| Agiliti Surgical, Inc. | 1 | $27 |
| Halozyme Inc | 1 | $22 |
| Calyxo, Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bulkamid$1,564
- AQUABEAM SYSTEM$1,129
- Axonics r-SNM System$790
- Axonics$774
- INTERSTIM$280
- GEMTESA$250
- TITAN$168
- Natesto$136
- BOTOX$125
- Erleada$125
- AquaBeam Robotic System$118
How this compares
$11,279 in reported general payments places this provider in the 80th percentile of 952 urology providers in New York.
Other urology in Yonkers
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Evan GoldfischerPoughkeepsie$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.